ES2062161T3 - Forma liquida estable de acido 5-aminosalicilico. - Google Patents

Forma liquida estable de acido 5-aminosalicilico.

Info

Publication number
ES2062161T3
ES2062161T3 ES90109011T ES90109011T ES2062161T3 ES 2062161 T3 ES2062161 T3 ES 2062161T3 ES 90109011 T ES90109011 T ES 90109011T ES 90109011 T ES90109011 T ES 90109011T ES 2062161 T3 ES2062161 T3 ES 2062161T3
Authority
ES
Spain
Prior art keywords
alkali
aminosalicylic acid
asa
solution
alkaline earth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90109011T
Other languages
English (en)
Inventor
Carey B Bottom
Margaret N Kwoka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Marion Merrell Dow Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marion Merrell Dow Inc filed Critical Marion Merrell Dow Inc
Application granted granted Critical
Publication of ES2062161T3 publication Critical patent/ES2062161T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)

Abstract

SE DESCUBRE UNA SOLUCION ACUOSA DE ACIDO 5-AMINOSALICILICO (5-ASA) Y UN ALCALI NO TOXICO, UN METAL ALCALI O UNA SAL METALICA DE TIERRA ALCALINA DE ACIDO 5-AMINOSALICILICO CON UN PH DE 3-5. LA BASE DE LAS SOLUCION ESTA FORMADA POR ACIDO 5-AMINOSALICILICO Y SU ALCALI, METAL ALCALI O SAL METALICA DE TIERRA ALCALINA. LAS SOLUCIONES TAMBIEN CONTIENEN UN ANTIOXIDANTE Y UN AGENTE METALICO COMPLEJIZADOR. EN SU PRACTICA PREFERIDA, LA SAL 5-ASA SE FORMA IN SITU POR ADICION DE UN ALCALI, METAL ALACLI O HIDROXIDO METALICO DE TIERRA ALCALINA A UNA SOLUCION DE 5-ASA. LA SOLUCION ES ESTABLE Y NO PRESENTA UNA DECOLORACION SIGNIFICATIVA DEBIDA A LA DESCOMPOSICION DEL 5-ASA EN PERIODOS PROLONGADOS DE TIEMPO.
ES90109011T 1989-05-15 1990-05-14 Forma liquida estable de acido 5-aminosalicilico. Expired - Lifetime ES2062161T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/352,064 US5010069A (en) 1989-05-15 1989-05-15 Stable liquid form of 5-aminosalicylic acid

Publications (1)

Publication Number Publication Date
ES2062161T3 true ES2062161T3 (es) 1994-12-16

Family

ID=23383642

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90109011T Expired - Lifetime ES2062161T3 (es) 1989-05-15 1990-05-14 Forma liquida estable de acido 5-aminosalicilico.

Country Status (8)

Country Link
US (1) US5010069A (es)
EP (1) EP0398207B1 (es)
JP (1) JPH0347161A (es)
AT (1) ATE109660T1 (es)
CA (1) CA2016825A1 (es)
DE (1) DE69011399T2 (es)
DK (1) DK0398207T3 (es)
ES (1) ES2062161T3 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1587392A (en) * 1991-03-15 1992-10-21 Norwich Eaton Pharmaceuticals, Inc. The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d)
EP0586488B1 (de) * 1991-06-07 1995-05-03 Byk Gulden Lomberg Chemische Fabrik GmbH Pharmazeutische klistierzubereitung
FR2738150B1 (fr) * 1995-09-01 1997-10-31 Synthelabo Utilisation de la sulphasalazine et de ses metabolites pour la fabrication d'un medicament utile dans le traitement de l'insuffisance veineuse et des ulceres veineux
IT1277663B1 (it) * 1995-09-28 1997-11-11 Crinos Industria Farmaco Sospensioni acquose stabili di mesalazina per uso topico
US6326364B1 (en) 1999-02-08 2001-12-04 Cedars-Sinai Medical Center Use of 5-aminosalicylates as antimicrobial agents
EP1642885B1 (en) 2000-08-29 2009-11-11 Biocon Limited Use of a pharmaceutical composition containing a para-aminophenyl acetic acid derivative for treating inflammatory conditions of the gastrointestinal tract
JP3805646B2 (ja) * 2001-05-25 2006-08-02 久光メディカル株式会社 医薬液剤
US8048924B2 (en) * 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
US20040087527A1 (en) * 2002-10-31 2004-05-06 Day Brian J. Methods for treatment of thiol-containing compound deficient conditions
JP4593469B2 (ja) * 2003-09-22 2010-12-08 杏林製薬株式会社 変色改善された５−アミノサリチル酸固形製剤およびその保存方法
US7417037B2 (en) * 2004-01-20 2008-08-26 The Board Of Regents Of The University Of Oklahoma Compositions and methods of treatment for inflammatory diseases
HUE028158T2 (en) 2004-07-07 2016-12-28 Biocon Ltd Synthesis of bound immunoregulatory compounds
US7645801B2 (en) * 2007-01-29 2010-01-12 Alaven Pharmaceutical Llc Reduced irritant enema for treatment of inflammatory bowel disease (IBD)
KR101420315B1 (ko) 2014-03-19 2014-07-17 남봉길 약학적 액제 조성물
US20160263152A1 (en) * 2015-03-14 2016-09-15 Gavis Pharmaceuticals Bowel cleansing composition with improved taste
AR108992A1 (es) * 2016-07-08 2018-10-17 Ferring Bv Formulaciones líquidas estabilizadas que contienen picosulfato
CN113350277A (zh) * 2021-06-30 2021-09-07 广东科伦药业有限公司 一种治疗化疗口腔黏膜炎的美沙拉秦含漱液及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2647853A (en) * 1949-11-29 1953-08-04 Lab Francais Chimiotherapie Injectable solution of salt of para-aminosalicylic acid
WO1981002671A1 (en) * 1980-03-20 1981-10-01 Ferring Farma Lab Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
DE3151196A1 (de) * 1981-12-23 1983-06-30 Kurt Heinz Prof. Dr. 7800 Freiburg Bauer Verfahren zur herstellung von gut loeslichen 5-aminosalicylsaeure-arzneimittelzubereitungen
US4664256A (en) * 1983-09-06 1987-05-12 Farmaceutisk Laboratorium Ferring A/S Packaged stable enema solution or suspension containing 5-aminosalicyclic acid
US4657900A (en) * 1983-09-27 1987-04-14 Rowell Laboratories Pharmaceutical article of manufacture comprising a bisulfite stabilized aqueous solution of 5-aminosalicylic acid and method
DK536987A (da) * 1987-10-14 1989-04-15 Ferring Farma Lab Anvendelse af 5-aminosalicylsyre (5-asa) til fremstilling af et farmaceutisk praeparat til anvendelse ved reperfusionsbehandling

Also Published As

Publication number Publication date
DK0398207T3 (da) 1994-10-03
JPH0347161A (ja) 1991-02-28
EP0398207B1 (en) 1994-08-10
DE69011399T2 (de) 1994-12-15
US5010069A (en) 1991-04-23
ATE109660T1 (de) 1994-08-15
CA2016825A1 (en) 1990-11-15
EP0398207A1 (en) 1990-11-22
DE69011399D1 (de) 1994-09-15

Similar Documents

Publication Publication Date Title
ATE109660T1 (de) Stabile flüssige formulierung von 5- aminosalizylsäure.
MY103234A (en) Bleaching composition
IE870248L (en) Pseudoplastic acidic compositions
FI960327A0 (fi) Alumiinisuolaliuosten valmistusmenetelmä
PH24628A (en) Solution containing lysozyme hydrochloride and dipotassium glycyrrhizinate
JPS57150645A (en) Manufacture of sodium salt aqueous solution of alpha-aminocarboxyic acid
SE7714473L (sv) Lagringsbar blandning som vid upplosning i vatten ger en losning med hog antimikrobiell verkan
GB1527473A (en) Production of 3,3-dimethyl-2-hydroxy-butyric acid and its salts
DE3568943D1 (en) A pharmaceutical formulation containing azapropazone
JPS574997A (en) Platina compound and its drug composition
JPS641798A (en) Detergent composition
GB934292A (en) Process for the preparation of heterocyclic compounds
NO960700L (no) Isotiazolonmateriale og fremgangsmåte til stabilisering av vandig isotiazolonlösning
GB2001642B (en) Preparation of aqueous solutions of alkali metal salts of armstrong acid
GB1199547A (en) Process for the Preparation of alpha-Ketoglutaric Acid.
EP0464304A3 (en) Marking fluid
DE3673099D1 (de) Alkalivertraegliche amphoterische sulfobetain-tenside.
DE3068259D1 (en) Directly injectable aqueous solutions of the alkali salts of canrenoic acid and of furosemide, and process for their production
GB1367435A (en) Production of ypsilon-amino-beta-hydroxybutanoic acid
DK494682A (da) Hoejalkaliske bejdse- eller rensemidler samt anvendelse heraf
ATE118753T1 (de) Herstellung konzentrierter wässriger polyphosphatlösungen.
JPS5359621A (en) Prevention of freezing of sodium glycinate solution
JPS57137395A (en) Concentrated alkyl sulfuric acid ester ammonium salt aqueous solution
JPS5499724A (en) Productin of alminiium from aqueous solution of alminium salts
KR840005085A (ko) N-(4-트리플루오로메틸페닐)-테트라클로로프탈라민산의 염의 제조방법

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 398207

Country of ref document: ES